BIOX logo

Bioceres Crop Solutions Corp. (BIOX)

$0.42

Quotes are delayed by 15 minutes.

1D

1W

1M

3M

6M

YTD

1Y

2Y

5Y

ALL

Key data on BIOX

Market cap

$26555860

EPS

-0.88

P/E ratio

--

Price to sales

0.36

Dividend yield

--

Beta

0.386047

Price on BIOX

Previous close

$0.43

Today's open

$0.43

Day's range

$0.42 - $0.44

52 week range

$0.35 - $5.15

Profile about BIOX

CEO

Federico Trucco

Employees

983

Headquarters

Rosario, Province of Santa Fe

Exchange

Nasdaq Global Select

Shares outstanding

63228239

Issue type

Common Stock

BIOX industries and sectors

Materials

Agriculture

News on BIOX

Bioceres Crop Solutions Corp. (BIOX) Q3 2026 Earnings Call Transcript

Bioceres Crop Solutions Corp. (BIOX) Q3 2026 Earnings Call Transcript

news source

Seeking Alpha • May 12, 2026

news preview

Bioceres Crop Solutions Reports Fiscal Third Quarter 2026 Financial and Operational Results

ROSARIO, Argentina--(BUSINESS WIRE)--Bioceres Crop Solutions Corp. (Bioceres) (NASDAQ: BIOX), a leader in the development and commercialization of productivity solutions designed to regenerate agricultural ecosystems while making crops more resilient to climate change, announced financial results for the fiscal third quarter ended March 31, 2026. Financial results are expressed in U.S. dollars and are presented in accordance with International Financial Reporting Standards. All comparisons in t.

news source

Business Wire • May 11, 2026

news preview

Bioceres Crop (BIOX) Reports Q3 Loss, Misses Revenue Estimates

Bioceres Crop (BIOX) came out with a quarterly loss of $0.16 per share versus the Zacks Consensus Estimate of a loss of $0.05. This compares to a loss of $0.02 per share a year ago.

news source

Zacks Investment Research • May 12, 2026

news preview

CORRECTING and REPLACING Bioceres Crop Solutions to Host Fiscal Third Quarter 2026 Financial Results Conference Call on Tuesday, May 12, 2026 at 8:30 a.m. Eastern Time

ROSARIO, Argentina--(BUSINESS WIRE)--The dial-in details of release dated May 4, 2026 have been revised. The US Toll Free dial-in number should read 1-833-461-5787; the International dial-in numbers link has been updated; and the Conference ID: should read 717574163. The updated release reads: BIOCERES CROP SOLUTIONS TO HOST FISCAL THIRD QUARTER 2026 FINANCIAL RESULTS CONFERENCE CALL ON TUESDAY, MAY 12, 2026 AT 8:30 A.M. EASTERN TIME Bioceres Crop Solutions Corp. (NASDAQ: BIOX) (“Bioceres” or t.

news source

Business Wire • May 5, 2026

news preview

Bioceres Crop Solutions to Host Fiscal Third Quarter 2026 Financial Results Conference Call on Tuesday, May 12, 2026 at 8:30 a.m. Eastern Time

ROSARIO, Argentina--(BUSINESS WIRE)--Bioceres Crop Solutions Corp. (NASDAQ: BIOX) (“Bioceres” or the “Company”), a leader in the development and commercialization of productivity solutions designed to regenerate agricultural ecosystems while making crops more resilient to climate change, will hold a conference call on Tuesday, May 12, 2026 at 8:30 a.m. Eastern Time to discuss its results for the fiscal third quarter ended March 31, 2026. A press release detailing these results will be issued pr.

news source

Business Wire • May 4, 2026

news preview

A Message from Our Chief Executive Officer

ROSARIO, Argentina--(BUSINESS WIRE)--Bioceres Crop Solutions Corp. (NASDAQ: BIOX): Dear Fellow Shareholders, This communication accompanies the filing of our Form 6-K for the second quarter of fiscal year 2026, covering the six-month period ended 31 December 2025. I want to speak directly to our shareholders about where we stand, what we are focused on, and how we are navigating a period that has been both challenging and clarifying for Bioceres. OUR CONTINUING BUSINESS — FOCUS AND DIRECTION Th.

news source

Business Wire • Mar 16, 2026

news preview

Bioceres Crop Solutions Corp. (BIOX) Shareholder/Analyst Call Prepared Remarks Transcript

Bioceres Crop Solutions Corp. (BIOX) Shareholder/Analyst Call Prepared Remarks Transcript

news source

Seeking Alpha • Jan 30, 2026

news preview

Bioceres Lenders Claim Default, And Dilution Risks Are Higher Than Ever

Bioceres reported 1Q26 results with continued revenue declines but improved gross margins and significant OpEx reductions, boosting profitability. BIOX faces severe financial risks, including default claims and lawsuits to accelerate over $100 million in debt, which it cannot cover with current cash. Equity holders face high dilution risk from convertible notes and potential asset sales, as the company cannot be evaluated as a going concern.

news source

Seeking Alpha • Nov 20, 2025

news preview

Bioceres Crop Solutions Corp. (BIOX) Q1 2026 Earnings Call Transcript

Bioceres Crop Solutions Corp. ( BIOX ) Q1 2026 Earnings Call November 13, 2025 8:30 AM EST Company Participants Paula Savanti - Head of Investor Relations Federico Trucco - Executive Chairman & CEO Conference Call Participants Austin Moeller - Canaccord Genuity Corp., Research Division Presentation Operator Good morning all, and thank you for joining us on today's Bioceres Crop Solutions Fiscal First Quarter 2026 Financial and Operational Results. My name is Drew, and I'll be the operator on the call today.

news source

Seeking Alpha • Nov 13, 2025

news preview

Bioceres Crop Solutions Reports Fiscal First Quarter 2026 Financial and Operational Results

ROSARIO, Argentina--(BUSINESS WIRE)--Bioceres Crop Solutions Corp. (Bioceres) (NASDAQ: BIOX), a leader in the development and commercialization of productivity solutions designed to regenerate agricultural ecosystems while making crops more resilient to climate change, announced financial results for the fiscal first quarter ended September 30, 2025. Financial results are expressed in U.S. dollars and are presented in accordance with International Financial Reporting Standards. All comparisons.

news source

Business Wire • Nov 12, 2025

news preview

¹ Disclosures

Get started with M1

Invest in Bioceres Crop Solutions Corp.

Open an M1 investment account to buy and sell Bioceres Crop Solutions Corp. commission-free¹. Build wealth for the long term using automated trading and transfers.

Invest in BIOX on M1